Bristol Myers Squibb to acquire schizophrenia drugmaker Karuna Therapeutics for $14B
Princeton-based Bristol Myers Squibb & Co. on Friday agreed to acquire Karuna Therapeutics Inc. for $330 ...
Read more
Princeton-based Bristol Myers Squibb & Co. on Friday agreed to acquire Karuna Therapeutics Inc. for $330 ...
Read more